| Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw Journal of Clinical Oncology 28 (1), 126-131, 2010 | 1374 | 2010 |
| Long-term follow-up of a large active surveillance cohort of patients with prostate cancer L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, ... J Clin oncol 33 (3), 272-277, 2015 | 1300 | 2015 |
| CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, ... American Journal of Neuroradiology 30 (3), 525-531, 2009 | 729 | 2009 |
| Celiac disease: summary A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, ... AHRQ evidence report summaries, 2004 | 455 | 2004 |
| Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control LY Zhang, G Krzentowski, A Albert, PJ Lefebvre Diabetes care 24 (7), 1275-1279, 2001 | 336 | 2001 |
| Genetic predictors of response to systemic therapy in esophagogastric cancer YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, ... Cancer discovery 8 (1), 49-58, 2018 | 313 | 2018 |
| Hereditary diffuse gastric cancer: updated clinical practice guidelines VR Blair, M McLeod, F Carneiro, DG Coit, JL D'Addario, JM van Dieren, ... The Lancet Oncology 21 (8), e386-e397, 2020 | 302 | 2020 |
| Hemorrhagic Transformation of Ischemic Stroke: Prediction with CT Perfusion1 RI Aviv, CD d'Esterre, BD Murphy, JJ Hopyan, B Buck, G Mallia, V Li, ... Radiology 250 (3), 867-877, 2009 | 242 | 2009 |
| Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience HB Musunuru, T Yamamoto, L Klotz, G Ghanem, A Mamedov, ... The Journal of urology 196 (6), 1651-1658, 2016 | 207 | 2016 |
| Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes A Loblaw, P Cheung, L D’Alimonte, A Deabreu, A Mamedov, L Zhang, ... Radiotherapy and Oncology 107 (2), 153-158, 2013 | 184 | 2013 |
| Quality of life (QOL) and symptom burden (SB) in patients with breast cancer J Hamer, R McDonald, L Zhang, S Verma, A Leahey, C Ecclestone, ... Supportive Care in Cancer 25, 409-419, 2017 | 183 | 2017 |
| Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography J Hopyan, A Ciarallo, D Dowlatshahi, P Howard, V John, R Yeung, ... Radiology 255 (1), 142-153, 2010 | 183 | 2010 |
| Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 176 | 2016 |
| Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers A Hird, E Chow, L Zhang, R Wong, J Wu, E Sinclair, C Danjoux, M Tsao, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 193-197, 2009 | 163 | 2009 |
| High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma R Buckstein, RS Kerbel, Y Shaked, R Nayar, C Foden, R Turner, CR Lee, ... Clinical cancer research 12 (17), 5190-5198, 2006 | 162 | 2006 |
| ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants X Luo, S Feurstein, S Mohan, CC Porter, SA Jackson, S Keel, M Chicka, ... Blood Advances 3 (20), 2962-2979, 2019 | 130 | 2019 |
| Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer N Salvo, L Zeng, L Zhang, M Leung, L Khan, R Presutti, J Nguyen, ... Clinical Oncology 24 (2), 139-148, 2012 | 123 | 2012 |
| Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction … G Morton, M McGuffin, HT Chung, CL Tseng, J Helou, A Ravi, P Cheung, ... Radiotherapy and Oncology 146, 90-96, 2020 | 122 | 2020 |
| Metastatic prostate cancer in men initially treated with active surveillance T Yamamoto, HB Musunuru, D Vesprini, L Zhang, G Ghanem, A Loblaw, ... The Journal of urology 195 (5), 1409-1414, 2016 | 119 | 2016 |
| Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial A Chiang, L Zeng, L Zhang, F Lochray, R Korol, A Loblaw, E Chow, ... International Journal of Radiation Oncology* Biology* Physics 86 (4), 638-642, 2013 | 117 | 2013 |
LoblawSunnybrook Health Sciences CentreVerified email at sunnybrook.ca
